News & Updates

Show Multimedia Only
Depression may elevate CVD and all-cause death risks in patients with T2D

Depression may elevate CVD and all-cause death risks in patients with T2D

28 Oct 2026 byKanas Chan

Depression is associated with greater risks of incident cardiovascular disease (CVD) and all-cause mortality in patients with type 2 diabetes (T2D), a population-based mediation analysis of 0.5 million Chinese people has shown.

28 Oct 2026
Tranquillo data support ritlecitinib for NSV

Tranquillo data support ritlecitinib for NSV

27 Oct 2026 byAudrey Abella

In two pivotal phase III Tranquillo studies, individuals with nonsegmental vitiligo (NSV) achieved significant and clinically meaningful improvements in facial and total body repigmentation after 52 weeks of treatment with oral ritlecitinib.

27 Oct 2026